US Stock MarketDetailed Quotes

HCWB HCW Biologics

Watchlist

0.680
-0.030-4.19%

Trading Nov 22 13:20 ET

28.54MMarket Cap-673P/E (TTM)

HCW Biologics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

47.64%-2.93M

48.23%-4.86M

0.94%-3.6M

-116.77%-22.51M

-2.78%-3.89M

-141.46%-5.59M

-249.16%-9.39M

-128.51%-3.64M

5.37%-10.39M

-12.22%-3.79M

Net income from continuing operations

20.98%-3.9M

-254.99%-15.28M

-47.28%-7.47M

-67.74%-24.99M

-97.10%-10.68M

-26.17%-4.94M

-22.61%-4.3M

-146.48%-5.07M

-15.85%-14.9M

-70.75%-5.42M

Operating gains losses

----

---15.63K

--0

----

Depreciation and amortization

-53.70%128.45K

-54.30%129.93K

-18.52%243.5K

58.14%1.14M

5.13%274.55K

68.84%277.45K

90.09%284.33K

109.30%298.85K

32.06%717.85K

143.02%261.16K

Other non cash items

--0

-300.00%-418

-179.99%-1.67K

-200.00%-626

-200.00%-627

0.00%209

-92.61%2.09K

--626

Change In working capital

155.57%614.93K

281.91%10.05M

242.19%3.38M

-286.61%-4.64M

-12.89%1M

-201.72%-1.11M

-1,573.08%-5.52M

899.48%986.71K

70.96%2.49M

252.36%1.15M

-Change in receivables

209.28%3.13K

154.77%248.91K

283.03%631.87K

-292.72%-1.12M

-1,228.74%-825.68K

66.74%-2.87K

-320.54%-454.48K

139.28%164.97K

-112.03%-284.7K

1.37%-62.14K

-Change in prepaid assets

162.25%125.24K

107.32%401.17K

66.02%302.64K

-294.04%-4.82M

8.71%683.42K

-1,994.85%-201.19K

-1,233.74%-5.48M

-86.79%182.29K

188.69%2.48M

201.74%628.67K

-Change in payables and accrued expense

159.33%486.56K

1,801.51%9.4M

247.65%2.5M

287.21%1.62M

97.45%1.23M

-171.64%-820.12K

278.66%494.25K

167.10%718.68K

-77.85%418.21K

951.96%621.19K

-Change in other current liabilities

--0

28.63%-56.54K

-154.78%-326.74K

-114.00%-83.75K

-113.92%-82.5K

-113.84%-81.27K

-531.63%-79.23K

---128.25K

---39.14K

Cash from discontinued investing activities

Operating cash flow

47.64%-2.93M

48.23%-4.86M

0.94%-3.6M

-116.77%-22.51M

-2.78%-3.89M

-141.46%-5.59M

-249.16%-9.39M

-128.51%-3.64M

5.37%-10.39M

-12.22%-3.79M

Investing cash flow

Cash flow from continuing investing activities

-100.40%-37.06K

101.19%18.57K

56.82%-129.71K

-74.18%3.8M

-5,309.54%-3.72M

37.52%9.37M

-11,959.46%-1.56M

-103.77%-300.39K

142.00%14.71M

-187.35%-68.69K

Net PPE purchase and sale

94.12%-37.06K

101.19%18.57K

56.82%-129.71K

39.63%-6.2M

-5,309.54%-3.72M

93.80%-630.05K

-11,959.46%-1.56M

-1,175.30%-300.39K

-21,640.32%-10.28M

-246.00%-68.69K

Net investment purchase and sale

----

-59.97%10M

--0

----

171.44%24.98M

--0

Cash from discontinued investing activities

Investing cash flow

-100.40%-37.06K

101.19%18.57K

56.82%-129.71K

-74.18%3.8M

-5,309.54%-3.72M

37.52%9.37M

-11,959.46%-1.56M

-103.77%-300.39K

142.00%14.71M

-187.35%-68.69K

Financing cash flow

Cash flow from continuing financing activities

31,576.24%2.8M

24,807.64%1.92M

222,022.78%4.22M

-100.23%-14.53K

61.73%-15.25K

-100.14%-8.9K

28.53%7.71K

-16.37%1.9K

-87.27%6.27M

-753.00%-39.85K

Net issuance payments of debt

31,281.84%2.8M

--1.92M

--1.72M

-100.59%-38.27K

---29.29K

---8.98K

--0

--6.45M

--0

Net common stock issuance

--0

131,528.62%2.5M

50.46%23.74K

140.82%14.04K

-94.98%84

28.53%7.71K

-16.37%1.9K

-99.97%15.78K

-4.44%5.83K

Net other financing activities

----

97.18%-190.55K

---45.68K

Cash from discontinued financing activities

Financing cash flow

31,576.24%2.8M

24,807.64%1.92M

222,022.78%4.22M

-100.23%-14.53K

61.73%-15.25K

-100.14%-8.9K

28.53%7.71K

-16.37%1.9K

-87.27%6.27M

-753.00%-39.85K

Net cash flow

Beginning cash position

-84.41%1.16M

-77.79%4.08M

-83.90%3.6M

90.32%22.33M

-57.21%11.22M

-51.69%7.45M

1.50%18.39M

90.32%22.33M

38.73%11.73M

73.38%26.22M

Current changes in cash

-104.32%-163.09K

73.29%-2.92M

112.42%488.98K

-276.78%-18.73M

-95.64%-7.63M

-65.09%3.77M

-305.70%-10.94M

-161.64%-3.94M

223.55%10.6M

-14.83%-3.9M

End cash Position

-91.10%998.22K

-84.41%1.16M

-77.79%4.08M

-83.90%3.6M

-57.21%11.22M

-51.69%7.45M

1.50%18.39M

90.32%22.33M

Free cash flow

52.35%-2.96M

55.76%-4.84M

5.21%-3.73M

-38.99%-28.72M

-97.26%-7.61M

50.18%-6.22M

-305.08%-10.95M

-143.77%-3.94M

-87.44%-20.66M

-13.59%-3.86M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	47.64%-2.93M	48.23%-4.86M	0.94%-3.6M	-116.77%-22.51M	-2.78%-3.89M	-141.46%-5.59M	-249.16%-9.39M	-128.51%-3.64M	5.37%-10.39M	-12.22%-3.79M
Net income from continuing operations	20.98%-3.9M	-254.99%-15.28M	-47.28%-7.47M	-67.74%-24.99M	-97.10%-10.68M	-26.17%-4.94M	-22.61%-4.3M	-146.48%-5.07M	-15.85%-14.9M	-70.75%-5.42M
Operating gains losses	----	----	----	---15.63K	--0	----	----	----	----	----
Depreciation and amortization	-53.70%128.45K	-54.30%129.93K	-18.52%243.5K	58.14%1.14M	5.13%274.55K	68.84%277.45K	90.09%284.33K	109.30%298.85K	32.06%717.85K	143.02%261.16K
Other non cash items	--0	--0	-300.00%-418	-179.99%-1.67K	-200.00%-626	-200.00%-627	-200.00%-627	0.00%209	-92.61%2.09K	--626
Change In working capital	155.57%614.93K	281.91%10.05M	242.19%3.38M	-286.61%-4.64M	-12.89%1M	-201.72%-1.11M	-1,573.08%-5.52M	899.48%986.71K	70.96%2.49M	252.36%1.15M
-Change in receivables	209.28%3.13K	154.77%248.91K	283.03%631.87K	-292.72%-1.12M	-1,228.74%-825.68K	66.74%-2.87K	-320.54%-454.48K	139.28%164.97K	-112.03%-284.7K	1.37%-62.14K
-Change in prepaid assets	162.25%125.24K	107.32%401.17K	66.02%302.64K	-294.04%-4.82M	8.71%683.42K	-1,994.85%-201.19K	-1,233.74%-5.48M	-86.79%182.29K	188.69%2.48M	201.74%628.67K
-Change in payables and accrued expense	159.33%486.56K	1,801.51%9.4M	247.65%2.5M	287.21%1.62M	97.45%1.23M	-171.64%-820.12K	278.66%494.25K	167.10%718.68K	-77.85%418.21K	951.96%621.19K
-Change in other current liabilities	--0	--0	28.63%-56.54K	-154.78%-326.74K	-114.00%-83.75K	-113.92%-82.5K	-113.84%-81.27K	-531.63%-79.23K	---128.25K	---39.14K
Cash from discontinued investing activities
Operating cash flow	47.64%-2.93M	48.23%-4.86M	0.94%-3.6M	-116.77%-22.51M	-2.78%-3.89M	-141.46%-5.59M	-249.16%-9.39M	-128.51%-3.64M	5.37%-10.39M	-12.22%-3.79M
Investing cash flow
Cash flow from continuing investing activities	-100.40%-37.06K	101.19%18.57K	56.82%-129.71K	-74.18%3.8M	-5,309.54%-3.72M	37.52%9.37M	-11,959.46%-1.56M	-103.77%-300.39K	142.00%14.71M	-187.35%-68.69K
Net PPE purchase and sale	94.12%-37.06K	101.19%18.57K	56.82%-129.71K	39.63%-6.2M	-5,309.54%-3.72M	93.80%-630.05K	-11,959.46%-1.56M	-1,175.30%-300.39K	-21,640.32%-10.28M	-246.00%-68.69K
Net investment purchase and sale	----	----	----	-59.97%10M	--0	----	----	----	171.44%24.98M	--0
Cash from discontinued investing activities
Investing cash flow	-100.40%-37.06K	101.19%18.57K	56.82%-129.71K	-74.18%3.8M	-5,309.54%-3.72M	37.52%9.37M	-11,959.46%-1.56M	-103.77%-300.39K	142.00%14.71M	-187.35%-68.69K
Financing cash flow
Cash flow from continuing financing activities	31,576.24%2.8M	24,807.64%1.92M	222,022.78%4.22M	-100.23%-14.53K	61.73%-15.25K	-100.14%-8.9K	28.53%7.71K	-16.37%1.9K	-87.27%6.27M	-753.00%-39.85K
Net issuance payments of debt	31,281.84%2.8M	--1.92M	--1.72M	-100.59%-38.27K	---29.29K	---8.98K	--0	--0	--6.45M	--0
Net common stock issuance	--0	--0	131,528.62%2.5M	50.46%23.74K	140.82%14.04K	-94.98%84	28.53%7.71K	-16.37%1.9K	-99.97%15.78K	-4.44%5.83K
Net other financing activities	----	----	----	----	----	----	----	----	97.18%-190.55K	---45.68K
Cash from discontinued financing activities
Financing cash flow	31,576.24%2.8M	24,807.64%1.92M	222,022.78%4.22M	-100.23%-14.53K	61.73%-15.25K	-100.14%-8.9K	28.53%7.71K	-16.37%1.9K	-87.27%6.27M	-753.00%-39.85K
Net cash flow
Beginning cash position	-84.41%1.16M	-77.79%4.08M	-83.90%3.6M	90.32%22.33M	-57.21%11.22M	-51.69%7.45M	1.50%18.39M	90.32%22.33M	38.73%11.73M	73.38%26.22M
Current changes in cash	-104.32%-163.09K	73.29%-2.92M	112.42%488.98K	-276.78%-18.73M	-95.64%-7.63M	-65.09%3.77M	-305.70%-10.94M	-161.64%-3.94M	223.55%10.6M	-14.83%-3.9M
End cash Position	-91.10%998.22K	-84.41%1.16M	-77.79%4.08M	-83.90%3.6M	-83.90%3.6M	-57.21%11.22M	-51.69%7.45M	1.50%18.39M	90.32%22.33M	90.32%22.33M
Free cash flow	52.35%-2.96M	55.76%-4.84M	5.21%-3.73M	-38.99%-28.72M	-97.26%-7.61M	50.18%-6.22M	-305.08%-10.95M	-143.77%-3.94M	-87.44%-20.66M	-13.59%-3.86M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data